Enhanced antitumor efficacy on hepatoma-bearing rats with adriamycin-loaded nanoparticles administered into hepatic artery

World Journal of Gastroenterology

Volumn 10, Issue 13, 2004, Pages 1989-1991

  Chen, Jiang Hao ^a   Ling, Rui ^a   Yao, Qing ^a   Wang, Ling ^a   Ma, Zhong ^a   Li, Yu ^b   Wang, Zhe ^b   Xu, Hu ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

DOXORUBICIN; NANOPARTICLE; SODIUM CHLORIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER INHIBITION; CANCER TRANSPLANTATION; CONTROLLED STUDY; DOSE RESPONSE; DOSE TIME EFFECT RELATION; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG FORMULATION; HEPATIC ARTERY; INTERMETHOD COMPARISON; LIFESPAN; LIVER CELL CARCINOMA; MALE; MICROENCAPSULATION; NONHUMAN; POLYMERIZATION; RANDOMIZATION; RAT; RAT STRAIN; STATISTICAL SIGNIFICANCE; SURVIVAL TIME; TUMOR NECROSIS; TUMOR VOLUME; WALKER CARCINOMA;

EID: 3543055289     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v10.i13.1989     Document Type: Article

References (9)

1. Ridge JA, Collin C, Bading JR, Hancock C, Conti PS, Daly JM, Raaf JH. Increased adriamycin levels in hepatic implants of rabbits Vx-2 carcinoma from regional infusion. Cancer Res 1988; 48: 4584-4587
2. Eksborg S, Cedermark BJ, Strandler HS. Intrahepatic and intravenous administration of adriamycin - a comparative pharmacokinetics study in patients with malignant liver tumours. Med Oncol Tumor Pharmacother 1985; 2: 47-54
3. Chiannilkulchai N, Ammoury N, Caillou B, Devissaguet JP, Couvreur P. Hepatic tissue distribution of doxorubicin-loaded nanoparticles after i.v. administration in reticulosarcoma M 5076 metastasis-bearing mice. Cancer Chemother Pharmacol 1990; 26: 122-126
4. Andrieu V, Fessi H, Dubrasquet M, Devissaguet JP, Puisieux F, Benita S. Pharmacokinetic evaluation of indomethacin nanocapsules. Drug Des Deliv 1989; 4: 295-302
5. Zou YY, Ueno M, Yamagishi M, Horikoshi I, Yamashita I, Tazawa K, Gu XQ. Targeting behavior of hepatic artery injected temperature sensitive liposomal adriamycin on tumor-bearing rats. Sel Cancer Ther 1990; 6: 119-127
6. Rupniak HT, Whelan RD, Hill BT. Concentration and time-dependent inter-relationships for antitumour drug cytotoxicities against tumour cells in vitro. Int J Cancer 1983; 32: 7-12
7. Astier A, Doat B, Ferrer MJ, Benoit G, Fleury J, Rolland A, Leverge R. Enhancement of adriamycin antitumor activity by its binding with an intracellular sustained-release form polymethacrylate nanospheres, in U-937 cells. Cancer Res 1988; 48: 1835-1841
8. Jordan A. Nanotechnology and consequences for surgical oncology. Kongressbd Dtsch Ges Chir Kongr 2002; 119: 821-828
9. Jia L, Wong H, Wang Y, Garza M, Weitman SD. Carbendazim: disposition, cellular permeability, metabolite identification, and pharmacokinetic comparison with its nanoparticle. J Pharm Sci 2003; 92: 161-172